C Courage

691 total citations
10 papers, 544 citations indexed

About

C Courage is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, C Courage has authored 10 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in C Courage's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Microtubule and mitosis dynamics (2 papers) and Smoking Behavior and Cessation (2 papers). C Courage is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Microtubule and mitosis dynamics (2 papers) and Smoking Behavior and Cessation (2 papers). C Courage collaborates with scholars based in United Kingdom, Japan and United States. C Courage's co-authors include Lesley Rushton, Leonard S. Levy, Raquel Duarte‐Davidson, Andreas J. Gescher, Joanna Budworth, Paul C. Rumsby, Alistair B.A. Boxall, Alexander C. Capleton, Philip V. Holmes and Roger T. Snowden and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

C Courage

10 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Courage United Kingdom 9 171 167 95 85 77 10 544
B. Leclercq France 18 252 1.5× 290 1.7× 95 1.0× 22 0.3× 51 0.7× 28 952
Pramila Singh United States 13 334 2.0× 78 0.5× 125 1.3× 79 0.9× 14 0.2× 39 607
Vita Marzia Italy 7 263 1.5× 72 0.4× 115 1.2× 116 1.4× 30 0.4× 9 500
C. Stuart Baxter United States 21 514 3.0× 550 3.3× 80 0.8× 168 2.0× 165 2.1× 65 1.6k
Jiange Zhang China 14 129 0.8× 214 1.3× 31 0.3× 65 0.8× 33 0.4× 22 633
Anne Platel France 14 207 1.2× 138 0.8× 145 1.5× 79 0.9× 16 0.2× 25 551
Alexander Böhme Germany 13 205 1.2× 101 0.6× 64 0.7× 30 0.4× 21 0.3× 27 559
Nana Asare Norway 9 311 1.8× 110 0.7× 128 1.3× 96 1.1× 15 0.2× 11 633
R. P. Bos Netherlands 13 560 3.3× 83 0.5× 87 0.9× 430 5.1× 29 0.4× 25 934
Kyoko Hiyoshi Japan 16 531 3.1× 193 1.2× 84 0.9× 77 0.9× 10 0.1× 20 944

Countries citing papers authored by C Courage

Since Specialization
Citations

This map shows the geographic impact of C Courage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Courage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Courage more than expected).

Fields of papers citing papers by C Courage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Courage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Courage. The network helps show where C Courage may publish in the future.

Co-authorship network of co-authors of C Courage

This figure shows the co-authorship network connecting the top 25 collaborators of C Courage. A scholar is included among the top collaborators of C Courage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Courage. C Courage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Capleton, Alexander C., C Courage, Paul C. Rumsby, et al.. (2006). Prioritising veterinary medicines according to their potential indirect human exposure and toxicity profile. Toxicology Letters. 163(3). 213–223. 94 indexed citations
2.
Courage, C, et al.. (2003). Reducing domestic exposure to environmental tobacco smoke: a review of attitudes and behaviours. The Journal of the Royal Society for the Promotion of Health. 123(1). 46–51. 28 indexed citations
3.
Rushton, Lesley, et al.. (2003). Estimation of the impact on children’s health of environmental tobacco smoke in England and Wales. The Journal of the Royal Society for the Promotion of Health. 123(3). 175–180. 18 indexed citations
4.
Duarte‐Davidson, Raquel, C Courage, Lesley Rushton, & Leonard S. Levy. (2001). Benzene in the environment: an assessment of the potential risks to the health of the population. Occupational and Environmental Medicine. 58(1). 2–13. 232 indexed citations
5.
Akiyama, Tadakazu, Makiko Shimizu, Tatsuya Tamaoki, et al.. (1999). Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).. PubMed. 59(17). 4406–12. 30 indexed citations
6.
Courage, C, et al.. (1997). Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine. International Journal of Cancer. 73(5). 763–768. 19 indexed citations
7.
Courage, C, et al.. (1997). Cellular relocalisation of protein kinase C-θ caused by staurosporine and some of its analogues. Biochemical Pharmacology. 53(10). 1413–1418. 20 indexed citations
8.
Courage, C, Roger T. Snowden, & Andreas J. Gescher. (1996). Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells. British Journal of Cancer. 74(8). 1199–1205. 29 indexed citations
9.
Courage, C, Joanna Budworth, & Andreas J. Gescher. (1995). Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. British Journal of Cancer. 71(4). 697–704. 66 indexed citations
10.
Prendiville, J, AT McGown, Andreas J. Gescher, et al.. (1994). Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1. British Journal of Cancer. 70(4). 573–578. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026